PRESSYN AR 20 UNIT / 1 ML — DIN 02246133
VASOPRESSIN (ARGININE VASOPRESSIN) : 20 UNIT / 1 ML · FERRING INC · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is PRESSYN AR?
PRESSYN AR 20 UNIT / 1 ML contains VASOPRESSIN (ARGININE VASOPRESSIN) : 20 UNIT / 1 ML. It is listed in the Health Canada Drug Product Database under DIN 02246133, held by FERRING INC, supplied as LIQUID for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 10-Mar-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Vasopressin (Argipressin) cost around the world?
Vasopressin (Argipressin) is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Saudi Arabia publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 3 | 3 | SAR███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| United Arab Emirates | public | 1 | 1 | AED███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
7 pack listings across 7 brand entries and 3 price bases, refreshed 01 Sep 2026. Ranges span every Vasopressin (Argipressin) pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Vasopressin (Argipressin) in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Vasopressin (Argipressin), across 6 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| FRESENIUS KABI CANADA LTD | 1 | 1 | VASOPRESSIN INJECTION, USP | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 1 | 1 | VASOPRESSIN INJECTION USP | Sourceable in Canada |
| FERRING INC | 2 | 0 | PRESSYN AR, VASOPRESSIN INJ 20UNIT/ML USP | No marketed DIN |
| LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | 1 | 0 | VASOPRESSIN INJ 20UNIT/ML USP | No marketed DIN |
| PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | 1 | 0 | PITRESSIN INJ 10 UNIT/0.5ML | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 20 UNIT / 1 ML |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAMUSCULAR ; SUBCUTANEOUS |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Vasopressin (Argipressin) |
|---|---|
| ATC code | H01BA01 |
| AHFS class | 68:28.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02246133 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2246133 |
| Brand name | PRESSYN AR |
| Generic / active ingredient | VASOPRESSIN (ARGININE VASOPRESSIN) : 20 UNIT / 1 ML |
| Market authorization holder | FERRING INC |
| Health Canada schedule | Prescription |
| ATC code | H01BA01 |
| ATC anatomical main group | H — Systemic hormonal preparations |
| ATC therapeutic subgroup | H01BA |
| Current status | CANCELLED POST MARKET |
| Status date | 10-Mar-2017 |
| Original market date | 2002-11-04 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Vasopressin (Argipressin) in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 6 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| VASOPRESSIN INJECTION USP | 20 UNIT | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02247938 |
| VASOPRESSIN INJECTION, USP | 20 UNIT | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02139502 |
| PITRESSIN INJ 10 UNIT/0.5ML | 10 UNIT / .5 ML | LIQUID | PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | 00222577 |
| VASOPRESSIN INJ 20UNIT/ML USP | 20 UNIT | LIQUID | FERRING INC | CANCELLED POST MARKET | 00693820 |
| VASOPRESSIN INJ 20UNIT/ML USP | 20 UNIT | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | 01944800 |
2 · Same class — other molecules in ATC H01BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Desmopressin | APO-DESMOPRESSIN · AURO-DESMOPRESSIN · BIPAZEN · DDAVP INJ 4MCG/ML · DDAVP MELT · DDAVP RHINYLE · DDAVP SPRAY · DDAVP TABLETS 0.1MG · DDAVP TABLETS 0.2MG · DESMOPRESSIN · DESMOPRESSIN SPRAY · DESMOPRESSIN TABLETS · MINIRIN · NOCDURNA · NU-DESMOPRESSIN SPRAY · OCTOSTIM LIQ INJ. 15MCG/ML · OCTOSTIM SPRAY · PMS-DESMOPRESSIN · TEVA-DESMOPRESSIN | 29 | 10 | Yes |
| Vasopressin (Argipressin) | PITRESSIN INJ 10 UNIT/0.5ML · PRESSYN AR · VASOPRESSIN INJ 20UNIT/ML USP · VASOPRESSIN INJECTION USP · VASOPRESSIN INJECTION, USP | 6 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC H01B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| H01BB | Carbetocin · Oxytocin | 7 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PRESSYN AR called?
The same molecule, Vasopressin (Argipressin), is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| EMBESIN | Latin | Bahrain |
| Progecta | Latin | Saudi Arabia |
| Vasopressin BOS | Latin | Saudi Arabia |
| Vatowis | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.